Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Onda

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2025
[Translational Research on Pre-eclampsia with Existing Drugs Targeting Antioxidant Molecules]Kenji Onda
Anticancer Research|July 3, 2019
Bevacizumab <i>Versus</i> Anti-preeclamptic Drugs: Evaluation With Three-dimensionally Co-cultured Human Mini TumorsChen Pan, Kenji Onda, Toshihiko Hirano
Frontiers in Pharmacology|March 13, 2023
Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting systemKenji Onda, Takeshi Honma, Koichi Masuyama
Frontiers in Drug Safety and Regulation|September 22, 2025
Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting systemTakeshi Honma, Kenji Onda, Koichi Masuyama
Frontiers in Pharmacology|May 7, 2026
Drug-drug interactions between sex hormones and analgesics linked to thromboembolic events: an FDA adverse event reporting system analysisSeiki Yamazaki, Kenji Onda, Koichi Masuyama
BMC Pharmacology & Toxicology|February 2, 2024
Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics useTakeshi Honma, Kenji Onda, Koichi Masuyama
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 2008
Suppression of blood lipid concentrations by volatile Maillard reaction productsKeisuke Kagami, Kenji Onda, Kitaro Oka, et al.
Phytotherapy Research : PTR|May 16, 2012
Polymethoxyflavonoids tangeretin and nobiletin increase glucose uptake in murine adipocytesKenji Onda, Natsumi Horike, Tai-ichi Suzuki, et al.
The Journal of Pharmacy and Pharmacology|August 23, 2008
Protective effect of caffeine on streptozotocin-induced beta-cell damage in ratsKeisuke Kagami, Hajime Morita, Kenji Onda, et al.
Biochemical and Biophysical Research Communications|February 26, 2009
Sofalcone, an anti-ulcer chalcone derivative, suppresses inflammatory crosstalk between macrophages and adipocytes and adipocyte differentiation: implication of heme-oxygenase-1 inductionHideaki Tanaka, Seito Nakamura, Kenji Onda, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2025
[Translational Research on Pre-eclampsia with Existing Drugs Targeting Antioxidant Molecules]Kenji Onda
Anticancer Research|July 3, 2019
Bevacizumab <i>Versus</i> Anti-preeclamptic Drugs: Evaluation With Three-dimensionally Co-cultured Human Mini TumorsChen Pan, Kenji Onda, Toshihiko Hirano
Frontiers in Pharmacology|March 13, 2023
Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting systemKenji Onda, Takeshi Honma, Koichi Masuyama
Frontiers in Drug Safety and Regulation|September 22, 2025
Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting systemTakeshi Honma, Kenji Onda, Koichi Masuyama
Frontiers in Pharmacology|May 7, 2026
Drug-drug interactions between sex hormones and analgesics linked to thromboembolic events: an FDA adverse event reporting system analysisSeiki Yamazaki, Kenji Onda, Koichi Masuyama
BMC Pharmacology & Toxicology|February 2, 2024
Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics useTakeshi Honma, Kenji Onda, Koichi Masuyama
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 2008
Suppression of blood lipid concentrations by volatile Maillard reaction productsKeisuke Kagami, Kenji Onda, Kitaro Oka, et al.
Phytotherapy Research : PTR|May 16, 2012
Polymethoxyflavonoids tangeretin and nobiletin increase glucose uptake in murine adipocytesKenji Onda, Natsumi Horike, Tai-ichi Suzuki, et al.
The Journal of Pharmacy and Pharmacology|August 23, 2008
Protective effect of caffeine on streptozotocin-induced beta-cell damage in ratsKeisuke Kagami, Hajime Morita, Kenji Onda, et al.
Biochemical and Biophysical Research Communications|February 26, 2009
Sofalcone, an anti-ulcer chalcone derivative, suppresses inflammatory crosstalk between macrophages and adipocytes and adipocyte differentiation: implication of heme-oxygenase-1 inductionHideaki Tanaka, Seito Nakamura, Kenji Onda, et al.
Pageof 7